when rimonabant will be approved
June 2008
People are asking when rimonabant will be approved.
Not for a few years...and possibly never.
Rimonabant (Acomplia, Zimulti) has been in the news as a promising drug for obesity, smoking cessation, dyslipidemia, and diabetes.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive